Shopping Cart
- Remove All
- Your shopping cart is currently empty
AM-1638 is an orally active GPR40/FFA1 agonist, useful for studying type II diabetes.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $893 | 8-10 weeks | |
50 mg | $1,160 | 8-10 weeks | |
100 mg | $1,740 | 8-10 weeks |
Description | AM-1638 is an orally active GPR40/FFA1 agonist, useful for studying type II diabetes. |
Targets&IC50 | FFA1/GPR40:0.16 μM |
In vivo | Methods: AM-1638 (1 mg/kg, IV) and (5 mg/kg, oral) were administered to mice; AM-1638 (0.5 mg/kg, IV) and (2 mg/kg, oral) were administered to rats; and AM-1638 (0.5 mg/kg, IV) and (2 mg/kg, oral) were administered to cynomolgus monkeys for pharmacokinetic studies. Results: Oral administration of AM-1638 showed excellent oral bioavailability (mice, >100%; rats, 72%; cynomolgus monkeys, 71%); and showed antidiabetic activity in BDF/DIO mice.[1] |
Alias | AM1638 |
Molecular Weight | 514.63 |
Formula | C33H35FO4 |
Cas No. | 1142214-62-7 |
Smiles | FC=1C(C2=C(C=C(COC3=CC([C@@H](CC(O)=O)[C@@H]4CC4)=CC=C3)C=C2)C=5C(C)(C)CCC5)=CC(OC)=CC1 |
Relative Density. | 1.193 g/cm3 (Predicted) |
Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (155.45 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.